Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/104515
DC FieldValueLanguage
dc.contributor.authorCalmeiro, João-
dc.contributor.authorMendes, Luís-
dc.contributor.authorDuarte, Iola F.-
dc.contributor.authorLeitão, Catarina-
dc.contributor.authorTavares, Adriana R.-
dc.contributor.authorFerreira, Daniel Alexandre-
dc.contributor.authorGomes, Célia-
dc.contributor.authorSerra, João-
dc.contributor.authorFalcão, Amílcar-
dc.contributor.authorCruz, Maria Teresa-
dc.contributor.authorCarrascal, Mylène A.-
dc.contributor.authorNeves, Bruno Miguel-
dc.date.accessioned2023-01-16T10:32:35Z-
dc.date.available2023-01-16T10:32:35Z-
dc.date.issued2020-
dc.identifier.issn1664-3224pt
dc.identifier.urihttps://hdl.handle.net/10316/104515-
dc.description.abstractDendritic cell (DC)-based antitumor vaccines have proven to be a safe approach, but often fail to generate robust results between trials. Translation to the clinic has been hindered in part by the lack of standard operation procedures for vaccines production, namely the definition of optimal culture conditions during ex-vivo DC differentiation. Here we sought to compare the ability of three clinical grade serum-free media, DendriMACS, AIM-V, and X-VIVO 15, alongside with fetal bovine serum-supplemented Roswell Park Memorial Institute Medium (RPMI), to support the differentiation of monocyte-derived DCs (Mo-DCs). Under these different culture conditions, phenotype, cell metabolomic profiles, response to maturation stimuli, cytokines production, allogenic T cell stimulatory capacity, as well as priming of antigen-specific CD8+ T cells and activation of autologous natural killer (NK) cells were analyzed. Immature Mo-DCs differentiated in AIM-V or X-VIVO 15 presented lower levels of CD1c, CD1a, and higher expression of CD11c, when compared to cells obtained with DendriMACS. Upon stimulation, only AIM-V or X-VIVO 15 DCs acquired a full mature phenotype, which supports their enhanced capacity to polarize T helper cell type 1 subset, to prime antigen-specific CD8+ T cells and to activate NK cells. CD8+ T cells and NK cells resulting from co-culture with AIM-V or X-VIVO 15 DCs also showed superior cytolytic activity. 1H nuclear magnetic resonance-based metabolomic analysis revealed that superior DC immunostimulatory capacities correlate with an enhanced catabolism of amino acids and glucose. Overall, our data highlight the impact of critically defining the culture medium used in the production of DCs for clinical application in cancer immunotherapy. Moreover, the manipulation of metabolic state during differentiation could be envisaged as a strategy to enhance desired cell characteristics.pt
dc.description.sponsorshipThis work was developed within the scope of iBiMED (UIDB/ 04501/2020) and CICECO-Aveiro Institute of Materials (UIDB/ 50011/2020 & UIDP/50011/2020), financed by national funds through the Foundation for Science and Technology (FCT). Funding was received from the project ImmunoDCs@ CancerStemCells: Cellular Immunotherapy toward the elimination of cancer stem cells (Ref.: POCI-01-0247-FEDER- 033532), co-funded by the European Regional Development Fund (FEDER), Competitiveness and Internationalization Operational Program (COMPETE2020) and Own Revenues of the University of Coimbra. João Calmeiro and Luı́s Mendes are supported by the FCT through individual PhD fellowships (PD/BDE/135076/2017; PD/BD/147220/2019). The NMR spectrometer is part of the National NMR Network (PTNMR), partially supported by Infrastructure Project N° 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC).-
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectcancer immunotherapypt
dc.subjectdendritic cells vaccinespt
dc.subjectclinical grade serum-free mediapt
dc.subjectmetabolic activitypt
dc.subjectdendritic cell differentiationpt
dc.subjectCTL primingpt
dc.subjectdendritic cell-NK cell crosstalkpt
dc.subject.meshBiomarkerspt
dc.subject.meshCell Differentiationpt
dc.subject.meshCytokinespt
dc.subject.meshCytotoxicity Tests, Immunologicpt
dc.subject.meshDendritic Cellspt
dc.subject.meshHumanspt
dc.subject.meshImmunophenotypingpt
dc.subject.meshKiller Cells, Naturalpt
dc.subject.meshLymphocyte Activationpt
dc.subject.meshNeoplasmspt
dc.subject.meshPhagocytosispt
dc.subject.meshPrimary Cell Culturept
dc.subject.meshBatch Cell Culture Techniquespt
dc.subject.meshCulture Media, Serum-Freept
dc.subject.meshImmunotherapypt
dc.titleIn-Depth Analysis of the Impact of Different Serum-Free Media on the Production of Clinical Grade Dendritic Cells for Cancer Immunotherapypt
dc.typearticle-
degois.publication.firstPage593363pt
degois.publication.titleFrontiers in Immunologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fimmu.2020.593363pt
degois.publication.volume11pt
dc.date.embargo2020-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.fulltextCom Texto completo-
item.openairetypearticle-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.researchunitICBR Coimbra Institute for Clinical and Biomedical Research-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.parentresearchunitFaculty of Medicine-
crisitem.author.orcid0000-0002-7497-4129-
crisitem.author.orcid0000-0002-3854-6549-
crisitem.author.orcid0000-0001-9846-6754-
Appears in Collections:FFUC- Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
I&D ICBR - Artigos em Revistas Internacionais
I&D CIBB - Artigos em Revistas Internacionais
I&D CIBIT - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
fimmu-11-593363.pdf8.91 MBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

9
checked on May 6, 2024

WEB OF SCIENCETM
Citations

7
checked on May 2, 2024

Page view(s)

64
checked on May 7, 2024

Download(s)

49
checked on May 7, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons